recent publications
-
academic article
- Tang, B., Capitao, C., Dean, B., Thomas, E. A. Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia Psychiatry Research 2012 196:201-206 DOI:10.1016/j.psychres.2011.09.026 PMID:22397921 PMCID:PMC3361581
- Tang, B., Dean, B., Thomas, E. A. Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders Translational Psychiatry 2011 1:e64 DOI:10.1038/tp.2011.61 PMID:22832356 PMCID:PMC3305989
- Udawela, M., Scarr, E., Hannan, A. J., Thomas, E. A., Dean, B. Phospholipase c beta 1 expression in the dorsolateral prefrontal cortex from patients with schizophrenia at different stages of illness Australian and New Zealand Journal of Psychiatry 2011 45:140-147 DOI:10.3109/00048674.2010.533364 PMID:21091263
- Torkamani, A., Dean, B., Schork, N. J., Thomas, E. A. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia Genome Research 2010 20:403-412 DOI:10.1101/gr.101956.109 PMID:20197298 PMCID:PMC2847743
- Gibbons, A. S., Thomas, E. A., Dean, B. Regional and duration of illness differences in the alteration of ncam-180 mrna expression within the cortex of subjects with schizophrenia Schizophrenia Research 2009 112:65-71 DOI:10.1016/j.schres.2009.04.002 PMID:19411161 PMCID:PMC2722680
- Narayan, S., Head, S. R., Gilmartin, T. J., Dean, B., Thomas, E. A. Evidence for disruption of sphingolipid metabolism in schizophrenia Journal of Neuroscience Research 2009 87:278-288 DOI:10.1002/jnr.21822 PMID:18683247 PMCID:PMC2606914
- Narayan, S., Tang, B., Head, S. R., Gilmartin, T. J., Sutcliffe, J. G., Dean, B., Thomas, E. A. Molecular profiles of schizophrenia in the cns at different stages of illness Brain Research 2008 1239:235-248 DOI:10.1016/j.brainres.2008.08.023 PMID:18778695 PMCID:PMC2783475
- Gibbons, A. S., Scarr, E., McOmish, C. E., Hannan, A. J., Thomas, E. A., Dean, B. Regulator of g-protein signalling 4 expression is not altered in the prefrontal cortex in schizophrenia Australian and New Zealand Journal of Psychiatry 2008 42:740-745 PMID:18622782
- Dean, B., Laws, S. M., Hone, E., Taddei, K., Scarr, E., Thomas, E. A., Harper, C., McClean, C., Masters, C., Lautenschlager, N., Gandy, S. E., Martins, R. N. Increased levels of apolipoprotein e in the frontal cortex of subjects with schizophrenia Biological Psychiatry 2003 54:616-622 DOI:10.1016/s0006-3223(03)00075-1 PMID:13129656
- Thomas, E. A., Laws, S. M., Sutcliffe, J. G., Harper, C., Dean, B., McClean, C., Masters, C., Lautenschlager, N., Gandy, S. E., Martins, R. N. Apolipoprotein d levels are elevated in prefrontal cortex of subjects with alzheimer's disease: No relation to apolipoprotein e expression or genotype Biological Psychiatry 2003 54:136-141 DOI:10.1016/s0006-3223(02)01976-5 PMID:12873803
- Thomas, E. A., Dean, B., Scarr, E., Copolov, D., Sutcliffe, J. G. Differences in neuroanatomical sites of apod elevation discriminate between schizophrenia and bipolar disorder Molecular Psychiatry 2003 8:167-175 DOI:10.1038/sj.mp.4001223 PMID:12610649
- Thomas, E. A., Dean, B., Pavey, G., Sutcliffe, J. G. Increased cns levels of apolipoprotein d in schizophrenic and bipolar subjects: Implications for the pathophysiology of psychiatric disorders Proceedings of the National Academy of Sciences of the United States of America 2001 98:4066-4071 DOI:10.1073/pnas.071056198 PMID:11274430 PMCID:PMC31180